IKT Forecast — Price Prediction for 2025. Should I Buy IKT?
1-Day-Price-Prediction
+4.43%
1-Week Prediction
+24.06%
1-Month Prediction
+122.75%
2026 Prediction
+44.27%
2030 Prediction
+59.29%
Based on our advanced algorithm, we predict that IKT stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $1.61, while the 1-week outlook suggests a value of $1.91. For the 1-month forecast, we project a price of $3.43. Looking further ahead, our 2026 projection estimates a value of $2.22, with a long-term 2030 forecast reaching $2.45. Stay informed and make strategic decisions with our data-driven insights!
Should I Buy Inhibikase Therapeutics Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. IKT has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
IKT stock price ended at $1.61 on Monday, after rising4.55%
The Inhibikase Therapeutics Inc stock price increased by 4.55% on the last trading day (15 Dec 2025), rising from 1.57 to 1.61. Throughout the last trading session, the stock experienced a fluctuation of 8.20% , ranging from a day low of $1.525 to a day high of 1.65. The price has declined in 3 of the last 10 days, resulting in a total change of 7.33% during this period. On the last day, trading volume decrease by 287.01K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 929.19K shares were traded, amounting to approximately 1.49M.
IKT Technical Signals
IKT(Inhibikase Therapeutics Inc Corp) has 4 buy signals and 5 sell signals now. The current trend is a downtrend starting from 2025-12-05. The total price change during this trend is +8.67%. Recently, the price has increased while volume droped, indicating a potential warning signal. The average turnover of IKT over the last 5 trading days is 761.94K. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
IKT Moving Average Analysis
Inhibikase Therapeutics Inc's overall moving average trend leans more bullish as of Monday, December 15, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $1.67, and $1.76. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.36, and $1.26. A break-down below any of these levels will issue sell signals.
IKT Short Selling Analysis
The short sale ratio of Inhibikase Therapeutics Inc(IKT) as of 10 Dec 2025 is 15.65%, dropping from last trading day. With decreasing price from 1.46 to 1.48. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
5
Buy
4
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 > 0
0.13
Bullish
Closing price
close > fibonacci_R1
1.63
Bullish
Moving Average
Price crosses above 60-day SMA
--
Bullish
Moving Average
5-day SMA crosses above 20-day SMA
--
Bullish
5 Bearish Signals
5 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Indicators
Signal
Value
Meaning
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 > 100
145.275
Bearish
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.0194
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.0055
Bearish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 > 80
100
Bearish
Williams %R (14 days)
WILLR_14 > -20
-8
Bearish
IKT Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Month
Min. Price
Avg. Price
Max. Price
Potential ROI
Jan 2026
$1.88
$2.22
$2.60
+20.75%
Feb 2026
$1.36
$1.64
$1.73
-10.75%
Mar 2026
$1.88
$1.97
$2.19
+7.18%
Apr 2026
$1.59
$1.95
$2.07
+5.71%
May 2026
$1.72
$2.10
$2.38
+13.91%
Jun 2026
$1.67
$1.86
$2.04
+1.13%
Jul 2026
$1.64
$1.64
$1.67
-10.75%
Aug 2026
$1.63
$1.85
$1.89
+0.64%
Sep 2026
$1.67
$1.99
$2.18
+8.05%
Oct 2026
$1.54
$1.81
$1.95
-1.37%
Nov 2026
$1.50
$1.64
$1.87
-10.75%
Dec 2026
$2.07
$2.22
$2.41
+20.75%
In 2026, Inhibikase Therapeutics Inc (IKT) is anticipated to change hands in a trading channel between $1.36 and $2.60.
Inhibikase Therapeutics Inc Stock Forecast 2026
Jan 2026: IKT Stock Forecast
Potential ROI: 20.75%
In Jan 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $2.22. The price is predicted to fluctuate between a low of $1.88 and a high of $2.60.
Feb 2026: IKT Stock Forecast
Potential ROI: -10.75%
In Feb 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $1.64. The price is predicted to fluctuate between a low of $1.36 and a high of $1.73.
Mar 2026: IKT Stock Forecast
Potential ROI: 7.18%
In Mar 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $1.97. The price is predicted to fluctuate between a low of $1.88 and a high of $2.19.
Apr 2026: IKT Stock Forecast
Potential ROI: 5.71%
In Apr 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $1.95. The price is predicted to fluctuate between a low of $1.59 and a high of $2.07.
May 2026: IKT Stock Forecast
Potential ROI: 13.91%
In May 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $2.10. The price is predicted to fluctuate between a low of $1.72 and a high of $2.38.
Jun 2026: IKT Stock Forecast
Potential ROI: 1.13%
In Jun 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $1.86. The price is predicted to fluctuate between a low of $1.67 and a high of $2.04.
Jul 2026: IKT Stock Forecast
Potential ROI: -10.75%
In Jul 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $1.64. The price is predicted to fluctuate between a low of $1.64 and a high of $1.67.
Aug 2026: IKT Stock Forecast
Potential ROI: 0.64%
In Aug 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $1.85. The price is predicted to fluctuate between a low of $1.63 and a high of $1.89.
Sep 2026: IKT Stock Forecast
Potential ROI: 8.05%
In Sep 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $1.99. The price is predicted to fluctuate between a low of $1.67 and a high of $2.18.
Oct 2026: IKT Stock Forecast
Potential ROI: -1.37%
In Oct 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $1.81. The price is predicted to fluctuate between a low of $1.54 and a high of $1.95.
Nov 2026: IKT Stock Forecast
Potential ROI: -10.75%
In Nov 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $1.64. The price is predicted to fluctuate between a low of $1.50 and a high of $1.87.
Dec 2026: IKT Stock Forecast
Potential ROI: 20.75%
In Dec 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $2.22. The price is predicted to fluctuate between a low of $2.07 and a high of $2.41.
IKT Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Inhibikase Therapeutics Inc(IKT), our algorithm predicts IKT's 1-month price at $1.59, with an 7.89%upwardshift. Using a similarity score up to 92.29%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Inhibikase Therapeutics Inc (IKT.O) stock, as of Sunday, November 2, 2025 , forecasts a 7.89% change over the next month, based on its high correlation with DNN.A stock patterns. The similarity between their price movements over the analyzed periods is 92.29%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
IKT
No data
DNN
Up: 7.89%Similarity: 92.29%
Name
Similarity
Up/Down
DNN.A
92.29%
+7.89%
MEC.N
91.26%
+17.42%
IBP.N
90.26%
+3.66%
IKT Seasonality Analysis
Based on IKT's historical stock price data across all years, the probability of a positive return in December is60.00%, suggesting it maybe an ideal month to invest in IKT. In contrast,Novemberoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Inhibikase Therapeutics Inc (IKT.O) stock in November has the highest probability of a positive return (80.00%), while June has the lowest probability (0.00%).
Performance Seasonality
The chart shows Inhibikase Therapeutics Inc. (IKT)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy Inhibikase Therapeutics Inc (IKT.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. IKT has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Inhibikase Therapeutics Inc (IKT.O) stock in a year?
The radar chart shows that buying Inhibikase Therapeutics Inc (IKT.O) stock in November has the highest probability of a positive return (80.00%), while June has the lowest probability (0.00%).
How has Inhibikase Therapeutics Inc. (IKT)'s stock price performed over the past three years?
IKT's stock price fell by -60.95% in 2023,increased by 143.99% in 2024, and went down by 51.06%in 2025.
Which bullish technical signals does IKT have?
Bullish technical signals of IKT include: MOM_10 > 0, close > fibonacci_R1, Price crosses above 60-day SMA, 5-day SMA crosses above 20-day SMA.
Is IKT a buy based on overall technical signals summary?
IKT has 4 buy signals and 5 sell signals now. Overall the technical rating for IKT is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of IKT.
What is the trend of Inhibikase Therapeutics Inc (IKT)'s moving average?
Inhibikase Therapeutics Inc's overall moving average trend leans more bullish as of December 15 2025, with 2 negative signals and 2 positive signal.
What is price prediction for IKT stock next month?
The price prediction chart for Inhibikase Therapeutics Inc (IKT.O) stock, as of November 02 2025, forecasts a 7.89% change over the next month, based on its high correlation with DNN stock patterns. The similarity between their price movements over the analyzed periods is 92.29%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2026 for Inhibikase Therapeutics Inc (IKT) Stock?
In Dec 2026, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $2.22. The price is predicted to fluctuate between a low of $2.07 and a high of $2.41.
What is price prediction 2030 for Inhibikase Therapeutics Inc (IKT) Stock?
In Dec 2030, Inhibikase Therapeutics Inc's value is forecasted to reach an average price of $2.45. The price is predicted to fluctuate between a low of $2.42 and a high of $2.81.
Positive
Negative
